Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

Jorgensen, H G and Allan, E K and Mountford, J C and Richmond, L and Elliott, M A and Holyoake, T L (2004) Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. Blood, 104 (11). 551A-551A. 1997. ISSN 0006-4971

Abstract

Meeting abstract 1997 looks at enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

ORCID iDs

Elliott, M A ORCID: https://orcid.org/0000-0002-9964-5671

• Share and Export
  

  RefWorksRIS (EndNote Online, Zotero, Ref manager, etc)RDF+XMLEndNoteASCII CitationOpenURL ContextObject in SpanMPEG-21 DIDLRIOXX2 XMLBibTeXAtomEP3 XMLDublin CoreRDF+N-TriplesMODSHTML CitationJSONData Cite XMLRDF+N3Multiline CSVOpenURL ContextObjectReferSimple MetadataMETS
• Item metadata

  Item type:	Article
  ID code:	34850
  Dates:	Date Event 16 November 2004 Published
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	21 Nov 2011 15:00
  Last modified:	11 Nov 2024 09:55
  URI:	https://strathprints.strath.ac.uk/id/eprint/34850